Adrenalin-Darnitsa 0.18% 1 ml N10 Amp

ADRENALIN-DARNITSA, solution for injection

Composition of ADRENALIN-DARNITSA

The composition of ADRENALIN-DARNITSA contains 1.82 mg of epinephrine hydrotartrate (adrenaline hydrotartrate) in 1 ml of solution. Excipients: sodium metabisulfite (Е 223), sodium chloride, water for injection.

ADRENALIN-DARNITSA indications

Slow-type allergic reactions: anaphylactic shock developing during the use of medicinal products, serum, or upon contact with allergens; bronchial asthma – relief of an attack; asystole, cardiac arrest; prolongation of the action duration of local anesthetics; acute development of 3rd degree AV block.

Contraindications

Individual high sensitivity to the components of the product; hypertrophic obstructive cardiomyopathy; severe aortic stenosis; tachyarrhythmia; ventricular fibrillation; pheochromocytoma; closed-angle glaucoma; shock (except for anaphylactic shock); general anesthesia with inhalation agents: halothane, cyclopropane, chloroform; the second stage of labor; use in the fingers and toes, nose, genital organs, and buttock area (risk of ischemic necrosis in tissues), discoloration of the solution.

Use during pregnancy and lactation

Controlled studies on the use of adrenaline in pregnant women have not been conducted. It is not used to correct arterial hypotension during labor because the product may prolong the second stage of labor by relaxing the uterine muscles. When used in high doses to weaken the contractile ability of the uterine muscle, it may cause prolonged atony of the uterus together with bleeding. If it is necessary to use the product during lactation, breastfeeding should be discontinued. Pediatric use: The product can be used in children.

ADRENALIN-DARNITSA, method of use

The product is prescribed subcutaneously, intramuscularly, sometimes intravenously, or by intravenous drip. For adults. Anaphylactic shock: the product is injected slowly into the vein in a diluted form at a dose of 0.5 ml (the single dose is dissolved in 20 ml of a 40% glucose solution). Then, if necessary, administration is continued by intravenous drip at a rate of 1 mcg/min— for this, 1 ml of adrenaline solution is dissolved in 400 ml of a 0.9% sodium chloride solution or in a 5% glucose solution. If the patient’s condition allows, it is more appropriate to inject 0.3–0.5 ml of the product intramuscularly or subcutaneously in diluted or undiluted form. ... (kept in short form)